These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27906832)

  • 1. Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients.
    Veenhof H; Koster RA; Alffenaar JC; Berger SP; Bakker SJL; Touw DJ
    Transplantation; 2017 Jul; 101(7):1727-1733. PubMed ID: 27906832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring.
    Veenhof H; Koster RA; Junier LAT; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2020 Sep; 58(10):1687-1695. PubMed ID: 32412437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots.
    Hinchliffe E; Adaway J; Fildes J; Rowan A; Keevil BG
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):106-9. PubMed ID: 23939194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
    Hinchliffe E; Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation.
    Al-Uzri A; Freeman KA; Wade J; Clark K; Bleyle LA; Munar M; Koop DR
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28635157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation.
    Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE
    Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dried blood spot measurement of tacrolimus is promising for patient monitoring.
    Hoogtanders K; van der Heijden J; Christiaans M; van de Plas A; van Hooff J; Stolk L
    Transplantation; 2007 Jan; 83(2):237-8. PubMed ID: 17264824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.
    Zwart TC; Gokoel SRM; van der Boog PJM; de Fijter JW; Kweekel DM; Swen JJ; Guchelaar HJ; Moes DJAR
    Br J Clin Pharmacol; 2018 Dec; 84(12):2889-2902. PubMed ID: 30176064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
    Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
    Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
    Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.
    Koster RA; Veenhof H; Botma R; Hoekstra AT; Berger SP; Bakker SJ; Alffenaar JC; Touw DJ
    Bioanalysis; 2017 Apr; 9(7):553-563. PubMed ID: 28300419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients.
    Veenhof H; Koster RA; Alffenaar JC; van den Berg AP; de Groot MR; Verschuuren EAM; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2019 Nov; 57(12):1854-1862. PubMed ID: 30939110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.
    van Boekel GA; Donders AR; Hoogtanders KE; Havenith TR; Hilbrands LB; Aarnoutse RE
    Eur J Clin Pharmacol; 2015 Jul; 71(7):811-6. PubMed ID: 25980838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.
    Sadilkova K; Busby B; Dickerson JA; Rutledge JC; Jack RM
    Clin Chim Acta; 2013 Jun; 421():152-6. PubMed ID: 23473895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients.
    Zwart TC; Metscher E; van der Boog PJM; Swen JJ; de Fijter JW; Guchelaar HJ; de Vries APJ; Moes DJAR
    Br J Clin Pharmacol; 2022 Nov; 88(11):4854-4869. PubMed ID: 35670960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.